<DOC>
	<DOCNO>NCT01227668</DOCNO>
	<brief_summary>The purpose study determine whether pediatric participant irritability associate autistic disorder respond aripiprazole treatment experience relapse significantly later continue therapy aripiprazole participant receive placebo</brief_summary>
	<brief_title>Phase IV Long-term Maintenance Study Aripiprazole Treatment Irritability Associated With Autistic Disorder</brief_title>
	<detailed_description>Phase 1 : Single blind/ Phase 2 : Double blind</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Key Male female child adolescent , 6 17 year age , inclusive , time baseline visit Meets current diagnostic criterion Diagnostic Statistical Manualof Mental Disorders IVText Revised autistic disorder display behavior tantrum , aggression , selfinjurious behavior , combination problem . Diagnosis autistic disorder confirm Autism Diagnostic InterviewRevised . Participant designate guardian caregiver able comprehend satisfactorily comply protocol requirement , opinion investigator . Demonstrates behavior tantrum , aggression , selfinjury combination problem An Aberrant Behavior Checklist Irritability subscale score ≥18 AND Clinical Global Impressions Severity score ≥4 Screening Baseline Visits . Mental age least 24 month Key Treatment resistant neuroleptic medication , base lack therapeutic response 2 different neuroleptic treatment least 3 week . Previous treatment aripiprazole least 3 week duration adequate daily dose , without demonstrate clinically meaningful response . Lifetime diagnosis bipolar disorder , psychosis , schizophrenia , current diagnosis major depressive disorder Diagnosis Pervasive Developmental DisorderNot Otherwise Specified , Asperger 's Syndrome , Rett 's Syndrome , childhood disintegrative disorder , Fragile X Syndrome History neuroleptic malignant syndrome At significant risk suicide base history routine psychiatric status examination A seizure within past year History severe head trauma stroke History current evidence unstable medical condition would expose patient undue risk significant adverse event interfere assessment safety efficacy course trial Weight low 15 kg Known allergy hypersensitivity aripiprazole dihidrocarbostyrils History clinically significant low white blood cell count druginduced leukopenia/neutropenia Any medically significant abnormal laboratory test vital sign result electrocardiogram finding</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>